Sanofi (ADR) (NYSE:SNY)

CAPS Rating: 4 out of 5

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.

Recs

0
Player Avatar line70day (< 20) Submitted: 12/10/2013 7:45:18 PM : Outperform Start Price: $49.58 SNY Score: -17.84

Devoloping Tasotere in treation non small-cell lung cancer .Peregrine hopes to serve as first step establishing its self as successful cancer -fighting agent.Is competition is catching up fast. Peregrin is using Bavituximab to treat cancer last monthreleased data showing that its antibodies produced tumor-fighting angents. Its sales of Celgene's Abrafane already has taken off.

Featured Broker Partners


Advertisement